Evidence map›Paper›PMID 40940628›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Painting Peptides With Antimicrobial Potency Through Deep Reinforcement Learning.

Ruihan Dong, Qiushi Cao, Chen Song

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Painting Peptides With Antimicrobial Potency Through Deep Reinforcement Learning.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ruihan DongCenter for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.
Qiushi CaoPeking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.
Chen SongCenter for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.ORCID https://orcid.org/0000-0001-9730-3216

Funding

Frontier Innovation Fund of Peking University Chengdu Academy for Advanced Interdisciplinary BiotechnologiesInnovative Research Group Project of the National Natural Science Foundation of China T2321001National Key R&D Program of China 2024YFA0916800
6 · The paper itself

Abstract

In the post-antibiotic era, antimicrobial peptides (AMPs) are considered ideal drug candidates because of their lower likelihood of inducing resistance. Computational models provide an efficient way to design novel AMPs. However, current optimization and generation approaches are tailored for specific application scenarios, which hinders the ease of use. To address this challenge, a novel AMP design model named AMPainter is proposed. Based on deep reinforcement learning, AMPainter integrates optimization and generation tasks in a unified framework. AMPainter is applied to three types of peptides, including known AMPs, signal peptides (SPs), and random sequences. AMPainter outperforms ten related models in enhancing the activity of known AMPs on the predicted antimicrobial potency and diversity. Several AMPs demonstrate a 128-fold decrease in their actual minimal inhibitory concentrations (MICs). AMPainter evolves effective AMPs from membrane-active SPs with an experimental success rate of 80%. In terms of generation, de novo designed AMP from an inactive random sequence achieves an average MIC of 2.88 µM against four bacteria. In vitro MICs of peptides along the virtual evolutionary path match the predicted scores. Therefore, AMPainter can significantly improve the antimicrobial potency of various peptides, expand the AMP sequence space, and discover novel antimicrobial agents.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsAntimicrobial PeptidesDeep LearningBacteriaDrug DesignMicrobial Sensitivity TestsReinforcement Machine LearningAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial Peptidesantimicrobial peptidedeep reinforcement learningdirected evolutionsequence design

Identifiers

PMID40940628
PMCPMC12631831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.